A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

Objective To evaluate the usefulness of biomarkers to predict the evolution of patients suspected of systemic lupus erythematosus (SLE), designated as probable SLE (pSLE), into classifiable SLE according to the American College of Rheumatology (ACR) classification criteria. Methods Patients suspecte...

Full description

Bibliographic Details
Main Authors: Rosalind Ramsey‐Goldman, Roberta Vezza Alexander, John Conklin, Cristina Arriens, Sonali Narain, Elena M. Massarotti, Daniel J. Wallace, Christopher E. Collins, Amit Saxena, Chaim Putterman, Kelley Brady, Kenneth C. Kalunian, Arthur Weinstein
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11219

Internet

https://doi.org/10.1002/acr2.11219

Similar Items